Overexpression of SR-BI in hamsters treated with a novel ACAT inhibitor (F12511)

Comptes Rendus de l'Academie des Sciences - Serie III

Volumn 324, Issue 3, 2001, Pages 229-234

  Milliat, Fabien ^a   Férézou, Jacqueline ^a   Delhon, André ^b   Lutton, Claude ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

ACAT inhibitor; Acyl coenzyme A; Atherosclerosis; Cholesterol acyltransferase inhibitor; Hamster; High density lipoprotein; Scavenger receptor class B type I

Indexed keywords

2',3',5' TRIMETHYL 4' HYDROXYDODECYLTHIOPHENYLACETANILIDE; CHOLESTEROL; CHOLESTEROL ACYLTRANSFERASE INHIBITOR; CHOLESTEROL ESTER; EFLUCIMIBE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN RECEPTOR; LOW DENSITY LIPOPROTEIN RECEPTOR; PHOSPHOLIPID; SCAVENGER RECEPTOR; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL ESTERIFICATION; CHOLESTEROL INTAKE; CONTROLLED STUDY; DRUG EFFECT; DRUG STRUCTURE; ENZYME INHIBITION; GENE OVEREXPRESSION; INTESTINE ABSORPTION; LIVER; MALE; NONHUMAN; PHOSPHOLIPID BLOOD LEVEL; RECEPTOR UPREGULATION; SYRIAN HAMSTER; TRIACYLGLYCEROL BLOOD LEVEL;

CRICETINAE; MUS MUSCULUS;

EID: 0035104157     PISSN: 07644469     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0764-4469(00)01299-3     Document Type: Article

References (39)

1. A receptor-mediated pathway for cholesterol homeostasis
2. Plasma high density lipoproteins. Metabolism and relationship to atherosclerosis
3. Why prefer the golden Syrian hamster (mesocricetus auratus) to the Wistar rat in experimental studies on plasma lipoprotein metabolism?
4. Biochemical changes, morphological alterations of liver and kidney in hamsters after administration of the HMG-coenzyme A reductase inhibitor, simvastatin: Prevention and reversibility by mevalonate
5. Effect of feeding psyllium and cholestyramine in combination on low density lipoprotein metabolism and fecal bile acid excretion in Hamsters with dietary-induced hypercholesterolemia
6. TMP-153, a novel ACAT inhibitor, lowers plasma cholesterol through its hepatic action in Golden hamsters
7. Role of acylcoenzyme A: Cholesterol O-acyltransferase
8. Role of acyl-CoA:cholesterol acyltransferase in cellular cholesterol metabolism
9. Secretion of very low density lipoproteins enriched in cholesteryl esters by cultured rat hepatocytes during stimulation of intracellular cholesterol esterification
10. Identification of Scavenger Receptor SR-BI as a high density lipoprotein receptor
11. Dissociation of tissue uptake of cholesterol from that of apoprotein-Al of rat high density lipoproteins: Selective delivery of cholesterol to liver, adrenal and gonad
12. A targeted mutation in the murine gene encoding the HDL receptor scavenger receptor class B type I reveals its key role in HDL metabolism
13. Targeted mutation reveals a central role for SR-BI in hepatic selective uptake of high density lipoprotein cholesterol
14. Liver-specific overexpression of SR-BI decreases levels of VLDL lipoprotein apoB, LDL lipoprotein apoB, and HDL lipoprotein in transgenic mice
15. Decreased atherosclerosis in heterozygous LDL lipoprotein receptor-deficient mice expressing the SR-BI transgene
16. Scavenger receptor BI (SR-BI) mediates free cholesterol flux independently of HDL tethering to the cell surface
17. Antilithiasic effect of β-cyclodextrin in LPN hamster: Comparison with cholestyramine
18. Protein measurement with Folin phenol reagent
19. Intestinal excretion of cholesterol: A mechanism for regulating plasma levels
20. Effects of insulin deficiency on lipoproteins and their hepatic receptors in Rico rats
21. Increased binding of low density lipoprotein to liver membranes from rats treated with 17α-ethinyl estradiol
22. Hypercholesterolemia induced by cholesterol-or cystine-enriched diets is characterized by different plasma lipoprotein and apolipoprotein concentrations in rats
23. Pharmacological profile of F12511, a powerful and systemic ACAT inhibitor
24. ACAT inhibitor HL-004 accelerates the regression of hypercholesterolemia in stroke-prone spontaneously hypertensive rats (SHRSP): Stimulation of bile acid production by HL-004
25. HMG-CoA reductase and ACAT inhibitors act synergistically to lower plasma cholesterol and limit atherosclerotic lesion development in the cholesterol-fed rabbit
26. Inhibitory effect of TS-962 on the formation of early atherosclerotic lesions of high fat-fed hyperlipidemic hamsters
27. TMP-153, a novel ACAT inhibitor, inhibits cholesterol absorption and lowers plasma cholesterol in rats and hamsters
28. Immunodepletion experiments suggest that acyl-coenzyme A: Cholesterol acyltransferase-1 (ACAT-1) protein plays a major catalytic role in adult human liver, adrenal gland, macrophages, and kidney, but not in intestines
29. Identification of a form of acyl-CoA: Cholesterol acyltransferase specific to liver and intestine in nonhuman primates
30. ACAT-2, a second mammalian acyl-CoA:Cholesterol acyltransferase. Its cloning, expression, and characterization
31. Scavenger receptor BI (SR-BI) is up-regulated in adrenal gland in apolipoprotein A-I and Hepatic Lipase knock-out mice as a response to depletion of cholesterol stores
32. F12511 exerts hypocholesterolemic effects in normocholesterolemic hamsters through hepatic ACAT inhibition
33. Diet modification alters plasma HDL cholesterol concentrations but not the transport of HDL cholesteryl esters to the liver in the hamster
34. Cholesteryl ester transfer activity in hamster plasma: Increase by fat and cholesterol rich diets
35. An overview of reverse cholesterol transport
36. Overexpression of the HDL receptor SR-BI alters plasma HDL and bile cholesterol levels
37. Biliary cholesterol excretion: A novel mechanism that regulates dietary cholesterol absorption
38. Identification of a receptor mediating absorption of dietary cholesterol in the intestine
39. Influence of the high density lipoprotein receptor SR-BI on reproductive and cardiovascular pathophysiology